AHCO News and Press, AdaptHealth Corp. From 05/06/21

AdaptHealth (NASDAQ: AHCO) , a company specializing in home medical equipment (HME), was not a healthy stock on Thursday. It cratered by 11.8% following the release of its first-quarter results. For the quarter, thanks in no small part to recent acquisitions, AdaptHealth booked ...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips In 2020, around 250 private businesses became public through mergers with special purpose acquisition companies (SPACs) that were already listed on an exchange. Now in 2021, that number has already reached 313. However, s...

Gainers: Stealth BioTherapeutics (MITO) +45%, Biofrontera (BFRA) +18%, BioCryst Pharmaceuticals (BCRX) +15%, Orgenesis (ORGS) +12%, GT Biopharma (GTBP) +4%.Losers: Regional Health Properties (RHE) -24%, VYNE Therapeutics (VYNE) ...

AdaptHealth (AHCO): Q1 GAAP EPS of -$0.08 misses by $0.30.Revenue of $482.1M (+151.8% Y/Y) misses by $4.21M.Increased FY21 Guidance:Net revenue of $2.22 billion to $2.39 billion, up from prior guidance of $2.18 billion to $2.35 billionAdjusted EBITDA of $525 million to $565 million, up from p...

AdaptHealth Corp. (NASDAQ: AHCO) (“AdaptHealth” or the “Company”) , a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services, announced today financial results f...

[[ACIW]], [[ADNT]], [[AES]], [[AHCO]], [[ALE]], [[APTV]], [[ARW]], [[AVYA]], [[AZUL]], [[BDX]], [[BIP]], [[BKI]], [[BLD]], [[BLDR]], [[BLL]], [[BUD]], [[BV]], [[CAH]], [[CARS]], [[CNP]], [[COMM]], [[CORE]], [[CWEN]], [[DEN]], [[DLX]], [[DOCN]], [[ECOM]], [[EPAM]], [[EPC]], [[EPZM]], [[EVOP]],...

AdaptHealth Corp. (NASDAQ: AHCO) (“AdaptHealth” or the “Company”) , a national leader in providing patient-centric and technology-enabled chronic disease management solutions including home healthcare equipment, medical supplies to the home and related se...

AdaptHealth Corp. (NASDAQ: AHCO) (“AdaptHealth” or the “Company”) , a national leader in providing patient-centric and technology-enabled chronic disease management solutions including home healthcare equipment, medical supplies to the home and related se...

Ongoing profitability a question mark at OrganigramCIBC analyst John Zamparo doesn't see Organigram Holdings (OGI) returning to positive EBIDTA soon, leading him to cut shares to underperformer and reducing his price target to C$3.25 from C$5.He says the COVID-19 pandemic will continue to imp...

Gainers: Mackinac Financial (MFNC) +56%.NovoCure (NVCR) +42%.vTv Therapeutics (VTVT) +42%.Digimarc (DMRC) +20%.PLBY Group (PLBY) +20%.Ballantyne Strong (BTN) +20%.Birks Group (BGI) +18%.Zai Lab (ZLAB) +16%.B. Riley Financial (RILY) +15%.Nam Tai Property (NTP) +14%.Losers: Brook...